KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) EBIAT (2016 - 2025)

Historic EBIAT for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $670.0 million.

  • Boston Scientific's EBIAT rose 1921.71% to $670.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 5674.8%. This contributed to the annual value of $2.9 billion for FY2025, which is 5666.31% up from last year.
  • Latest data reveals that Boston Scientific reported EBIAT of $670.0 million as of Q4 2025, which was up 1921.71% from $755.0 million recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's EBIAT ranged from a high of $795.0 million in Q2 2025 and a low of $95.0 million during Q4 2021
  • Moreover, its 5-year median value for EBIAT was $380.0 million (2021), whereas its average is $403.4 million.
  • Per our database at Business Quant, Boston Scientific's EBIAT skyrocketed by 300000.0% in 2021 and then tumbled by 6774.19% in 2022.
  • Over the past 5 years, Boston Scientific's EBIAT (Quarter) stood at $95.0 million in 2021, then surged by 47.37% to $140.0 million in 2022, then soared by 260.0% to $504.0 million in 2023, then grew by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025.
  • Its EBIAT was $670.0 million in Q4 2025, compared to $755.0 million in Q3 2025 and $795.0 million in Q2 2025.